Fluicell AB (publ) (STO:FLUI)
31.30
-0.10 (-0.32%)
Jul 24, 2026, 3:38 PM CET
Fluicell AB Revenue
Fluicell AB had revenue of 8.42M SEK in the quarter ending March 31, 2026, with 135.23% growth. This brings the company's revenue in the last twelve months to 20.35M, up 48.99% year-over-year. In the year 2025, Fluicell AB had annual revenue of 15.51M with 46.79% growth.
Revenue (ttm)
20.35M
Revenue Growth
+48.99%
P/S Ratio
2.13
Revenue / Employee
1.83M
Employees
11
Market Cap
43.00M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 15.51M | 4.94M | 46.79% |
| Dec 31, 2024 | 10.57M | 5.94M | 128.16% |
| Dec 31, 2023 | 4.63M | -2.41M | -34.24% |
| Dec 31, 2022 | 7.04M | 3.05M | 76.49% |
| Dec 31, 2021 | 3.99M | -880.00K | -18.07% |
| Dec 31, 2020 | 4.87M | 2.28M | 87.96% |
| Dec 31, 2019 | 2.59M | 1.37M | 111.34% |
| Dec 31, 2018 | 1.23M | 150.00K | 13.94% |
| Dec 31, 2017 | 1.08M | -1.58M | -59.43% |
| Dec 31, 2016 | 2.65M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Magle Chemoswed Holding AB | 273.25M |
| ExpreS2ion Biotech Holding AB | 16.12M |
| AcouSort AB | 10.05M |
| Spago Nanomedical AB | 4.38M |
| 2cureX AB | 1.98M |
| Pila Pharma AB | 1.13M |
| Alligator Bioscience AB | 520.00K |
Fluicell AB News
- 2 months ago - Fluicell AB Quarterly report: Q1 2026 - Filings
- 5 months ago - Fluicell AB Annual report: Q4 2025 - Filings
- 5 months ago - Fluicell AB Quarterly report: Q4 2025 - Filings
- 8 months ago - Fluicell AB Quarterly report: Q3 2025 - Filings
- 11 months ago - Fluicell AB Quarterly report: Q2 2025 - Filings